CRH Medical Corporation CRHM
— —
Day range unavailable
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 3.40
- Target (low)
- 3.00
- Target (mean)
- 3.40
- Target (high)
- 4.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
- Strong buy1
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.04 | 0.03 – 0.04 | 0.05 | -20.0% | 27.81M | +7.7% | 2 |
| Next quarter | 0.03 | 0.03 – 0.03 | 0.02 | +50.0% | 22.51M | -0.1% | 1 |
| Current year | 0.08 | 0.07 – 0.08 | 0.15 | -46.7% | 95.75M | +22.2% | 3 |
| Next year | 0.06 | 0.03 – 0.11 | 0.08 | -25.0% | 97.84M | +2.2% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 9, 2021 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Feb 9, 2021 | Canaccord Genuity | Downgrade | Buy | Hold |
| Jun 26, 2020 | Canaccord Genuity | Maintained | — | Buy |
| May 14, 2020 | Canaccord Genuity | Maintained | — | Buy |
| Mar 13, 2020 | Canaccord Genuity | Maintained | — | Buy |
| Sep 1, 2017 | Cantor Fitzgerald | Downgrade | Buy | Neutral |
| Aug 4, 2017 | Canaccord Genuity | Maintained | — | Buy |
| Jul 24, 2017 | Scotiabank | Upgrade | — | Sector Outperform |
| Jul 18, 2017 | TD Securities | Downgrade | Buy | Hold |
| Dec 2, 2016 | Cantor Fitzgerald | Initiated | — | Buy |
| Mar 17, 2016 | Canaccord Genuity | Initiated | — | Buy |